Simona Armanca, PharmD, BCOP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Round table discussion
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
    Relationship end date:
    03/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Medical team workshop
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
    Relationship end date:
    07/12/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond